Anemia
News
Study provides new insights regarding HSCs, FA
with Fanconi anemia Image by Michael Milsom Environmental stress is a major factor driving DNA damage in hematopoietic stem cells (HSCs),...
News
Donor telomere length linked to survival after HSCT
Photo by Chad McNeeley Leukocyte telomere length is associated with survival in patients who undergo hematopoietic stem cell transplant (HSCT) to...
News
Product deemed breakthrough for beta-thalassemia major
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to LentiGlobin® BB305 for the treatment of transfusion-...
News
Studies shed new light on HSPC mobilization
in the bone marrow Two new studies have revealed elements that are key to hematopoietic stem and progenitor cell (HSPC) mobilization. In one...
News
Label changes report new side effects for hematology drugs
Credit: CDC Several hematology drugs approved by the US Food and Drug Administration (FDA) have recently undergone label changes to reflect newly...
News
Platelet transfusions may increase risk of death
Platelet transfusions may increase the risk of death in patients with platelet consumptive disorders, results of a large study suggest....
News
IPT doesn’t seem to benefit children with anemia
one of the trials took place Credit: Gabrielle Tenenbaum Intermittent preventive antimalarial treatment (IPT) does not provide much benefit for...
News
Cord blood product gets orphan designation
Credit: NHS The US Food and Drug Administration (FDA) has granted orphan designation to a cord blood product called NiCord for the treatment of...
News
Treated RBCs prove comparable to controls
Credit: UAB Hospital The process of pathogen inactivation does not compromise the quality of red blood cells (RBCs), results of a phase 3 study...
Conference Coverage
Drug combats complications of SCD
SAN FRANCISCO—Pharmaceutical-grade L-glutamine can reduce the risk of complications in patients with sickle cell disease (SCD), according to new...
News
FDA extends approved use of neutropenia drug
The US Food and Drug Administration (FDA) has approved tbo-filgrastim (Granix) injection for administration by patients and caregivers, allowing...